Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-10-05

Clinical Trial Update: CYA Versus MMF for Treatment of Moderate-Severe Psoriasis. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing cyclosporine A versus mycophenolate mofetil for moderate-to-severe psoriasis, with the current trial status listed as unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclosporine A (cyclosporine)
  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: University Hospital Muenster | Conditions: Psoriasis | Phase 2 | Status: UNKNOWN